(S)-Methyl 2-(morpholin-3-yl)acetate hydrochloride
≥95%
- Product Code: 60134
CAS:
1799443-47-2
| Molecular Weight: | 195.64 g./mol | Molecular Formula: | C₇H₁₄ClNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28401047 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a morpholine ring, makes it valuable in the development of drugs targeting neurological and cardiovascular conditions. It is often employed in the preparation of compounds with potential therapeutic effects, such as inhibitors or modulators of specific enzymes or receptors. Additionally, its chiral nature allows for the creation of enantiomerically pure substances, which is critical in designing drugs with higher efficacy and reduced side effects. Researchers also use it in medicinal chemistry studies to explore structure-activity relationships and optimize drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $859.32 |
+
-
|
| 1.000 | 10-20 days | $1,718.63 |
+
-
|
(S)-Methyl 2-(morpholin-3-yl)acetate hydrochloride
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a morpholine ring, makes it valuable in the development of drugs targeting neurological and cardiovascular conditions. It is often employed in the preparation of compounds with potential therapeutic effects, such as inhibitors or modulators of specific enzymes or receptors. Additionally, its chiral nature allows for the creation of enantiomerically pure substances, which is critical in designing drugs with higher efficacy and reduced side effects. Researchers also use it in medicinal chemistry studies to explore structure-activity relationships and optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :